QF Entity performs first pediatric vocal cord injection medialization procedure 06 February 2024, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has expanded its pediatric Otolaryngology (ear, nose and throat)
In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings have been published in the prestigious New England Journal of Medicine.
24 January 2024, Doha, Qatar – Researchers at Sidra Medicine, a member of Qatar Foundation, in collaboration with teams from the Universidade Federal do Rio Grande do Sul (Brazil) and Monell Chemical
21 January 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is proud to announce that one of its research studies published in Nature Medicine in May 2023, has been featured in
Sidra Medicine and Hamad Medical Corporation will co-host the 8th Qatar Pediatric Emergency Conference (QPEM) from 19 to 21 January 2024. QPEM 2024 aims is to provide high-quality, evidence-based updates for healthcare practitioners involved in the urgent and emergent care of children.
11 December, 2023, Doha, Qatar – Sidra Medicine (a member of Qatar Foundation) and Nazarbayev University in Kazakhstan, have signed a Memorandum of Understanding (MoU) to establish and develop levels of cooperation and
Direct billing now available for eligible insured members served by GlobeMed 10 November 2023, Doha, Qatar – Sidra Medicine, a Qatar Foundation entity, and GlobeMed Qatar, a leading healthcare benefits management company in
15 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) has initiated a new phase in cancer care, with its pediatric cancer research program, to advance the cutting-edge diagnosis, early detection and
Sidra Medicine Launches Good Manufacturing Practices (GMP) Facility Focus on Precision Medicine in Pediatric Cancers 14 November 2023, Doha, Qatar – Sidra Medicine (a QF entity) today announced the launch of its Good
